Farther Finance Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Farther Finance Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.74K	Sell	49 -60	-55%	-$6.02K	﹤0.01%	4732
2026 Q1	$10.3K	Buy	109 +75	+221%	+$7.05K	﹤0.01%	4087
2025 Q4	$2.69K	Buy	34 +17	+100%	+$1.22K	﹤0.01%	4574
2025 Q3	$1.25K	Buy	17 +11	+183%	+$699	﹤0.01%	4306
2025 Q2	$305	Buy	6 +3	+100%	+$134	﹤0.01%	4134
2025 Q1	$132	Hold	3	–	–	﹤0.01%	4030
2024 Q4	$124	Hold	3	–	–	﹤0.01%	3752
2024 Q3	$117	Hold	3	–	–	﹤0.01%	3755
2024 Q2	$102	Buy	+3	New	+$79	﹤0.01%	3597

Other funds holding MIRM

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

SAM

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Farther Finance Advisors's MIRM Position: Q2 2026 in Review

Farther Finance Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 55% in Q2 2026, selling an estimated $6.02K and leaving 49 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #4732.

Farther Finance Advisors first reported a position in MIRM in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.3K in Q1 2026. 40 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Farther Finance Advisors held 49 shares of Mirum Pharmaceuticals worth $5.74K as of Q2 2026.
Farther Finance Advisors sold 60 Mirum Pharmaceuticals shares in Q2 2026, an estimated $6.02K.
Mirum Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4732 holding.
Farther Finance Advisors first reported a position in Mirum Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Farther Finance Advisors's Mirum Pharmaceuticals position peaked at $10.3K in Q1 2026.
40 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.